A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/28/2006	WO2006138510A1 Substituted enaminones as nicotinic acetylcholine receptor modulators
12/28/2006	WO2006138507A1 Use of sanglifehrin in hcv
12/28/2006	WO2006138503A2 New regimens for oral monophasic contraceptives
12/28/2006	WO2006138487A2 Treatment of ischemia-induced arrhythmias
12/28/2006	WO2006138475A2 Mao-b inhibitors useful for treating obesity
12/28/2006	WO2006138466A2 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
12/28/2006	WO2006138431A2 Methods and pharmaceutical formulations for increasing bioavailability
12/28/2006	WO2006138427A2 Combretastatin analogs with tubulin binding activity
12/28/2006	WO2006138418A2 Improvement of cognitive performance with sirtuin activators
12/28/2006	WO2006138385A2 Use of phenserine and analogs to treat behavioral problems and improve trainability
12/28/2006	WO2006138376A1 Prodrugs of a2b adenosine receptor antagonists
12/28/2006	WO2006138373A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
12/28/2006	WO2006138372A2 Methods and reagents for the treatment of inflammatory disorders
12/28/2006	WO2006138350A2 Chemokine receptor binding compounds
12/28/2006	WO2006138349A1 Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease including sage and rosemary derived compounds
12/28/2006	WO2006138328A1 Process for the production of antidiabetic oxazolidinediones
12/28/2006	WO2006138317A2 Dosage regimen for prasugrel
12/28/2006	WO2006138304A2 Pyrimidine compounds
12/28/2006	WO2006138266A2 The preparation and use of compounds as aspartyl protease inhibitors
12/28/2006	WO2006138264A2 Aspartyl protease inhibitors
12/28/2006	WO2006138259A2 Chemokine receptor binding compounds
12/28/2006	WO2006138253A1 Pharmaceutical compositions of hops resins
12/28/2006	WO2006138243A2 Inhibition of creatine uptake to promote weight loss
12/28/2006	WO2006138227A1 Modified and immediate release memantine bead formulation
12/28/2006	WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists
12/28/2006	WO2006138214A1 Nanoparticulate clopidogrel and aspirin combination formulations
12/28/2006	WO2006138212A1 SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
12/28/2006	WO2006138202A2 Pharmaceutical formulations for minimizing drug-drug interactions
12/28/2006	WO2006138195A1 Macrocyclic heterocyclic aspartyl protease inhibitors
12/28/2006	WO2006138192A1 Aspartyl protease inhibitors
12/28/2006	WO2006138187A1 Enhanced tissue penetration prodrugs
12/28/2006	WO2006138186A1 Two-component pharmaceutical composition for the treatment of pain
12/28/2006	WO2006138180A1 Tubulin inhibitor and process for its preparation
12/28/2006	WO2006138163A2 Anti-hypercholesterolemic compounds
12/28/2006	WO2006138155A1 Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
12/28/2006	WO2006138118A2 Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compounds
12/28/2006	WO2006138099A2 Bone morphogenetic protein formulations
12/28/2006	WO2006138048A2 Formulations comprising fluphenazine or derivatives thereof
12/28/2006	WO2006138038A1 Intralesional treatment of psoriasis
12/28/2006	WO2006138035A1 Vehicle for the delivery of topical lipid soluble pharmaceutical agents
12/28/2006	WO2006137958A1 Cyclodextrin inclusion complexes and methods of preparing same
12/28/2006	WO2006137840A2 Diphenyl ether antimicrobial compounds
12/28/2006	WO2006137839A2 Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
12/28/2006	WO2006137797A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
12/28/2006	WO2006137796A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
12/28/2006	WO2006137795A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions
12/28/2006	WO2006137794A1 New2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
12/28/2006	WO2006137793A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
12/28/2006	WO2006137792A1 New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions
12/28/2006	WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
12/28/2006	WO2006137790A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
12/28/2006	WO2006137789A1 Quinoline 3 -sulfonate esters as NK3 receptor modulators
12/28/2006	WO2006137782A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
12/28/2006	WO2006137772A1 New physical form of n,n´- disubstituted oxabispidines
12/28/2006	WO2006137771A1 Process for the preparation of sulfonic acid salts of oxabispidines
12/28/2006	WO2006137770A1 Process for the preparation of n,n´- disubstituted oxabispidines
12/28/2006	WO2006137706A1 6-(4-substituted-anilino)pyrimidine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same
12/28/2006	WO2006137658A1 New substituted 1,3-thiazole derivatives or pharmaceutically acceptable salts thereof having immunosuppression and inflammation inhibitory acitivity, intermediate compounds or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and pharmaceutical composition comprising the same
12/28/2006	WO2006137595A1 Prophylactic/therapeutic agent for her2-expressing cancer
12/28/2006	WO2006137546A1 Treatment method for preventing transplantation tissue with biological origin from calcification and tissue treated thereby
12/28/2006	WO2006137527A1 Thiazole derivative
12/28/2006	WO2006137514A1 Therapeutic agent for cancer comprising substance capable of inhibiting expression or function of synoviolin as active ingredient and screening method for the therapeutic agent for cancer
12/28/2006	WO2006137510A1 Agent for reduction of bleeding in cerebrovascular disorder
12/28/2006	WO2006137509A1 Cyclic amine derivative containing ppar regulator
12/28/2006	WO2006137490A1 Therapeutic agent for restenosis
12/28/2006	WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof
12/28/2006	WO2006137474A1 Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same
12/28/2006	WO2006137472A1 Prostaglandin derivative
12/28/2006	WO2006137469A1 Metabotropic glutamate receptor activator
12/28/2006	WO2006137466A1 Pharmaceutical composition
12/28/2006	WO2006137465A1 Nitrogenated heterocyclic derivative
12/28/2006	WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof
12/28/2006	WO2006137443A1 Tablet containing hardly soluble active ingredient
12/28/2006	WO2006137441A1 Anti-fatigue composition
12/28/2006	WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller
12/28/2006	WO2006137433A1 Aqueous preparation having levocabastine solubilized therein
12/28/2006	WO2006137423A1 Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli
12/28/2006	WO2006137421A1 Agent for topical administration
12/28/2006	WO2006137377A1 Neuronal regeneration promoter
12/28/2006	WO2006137368A1 Preventive or remedy for glaucoma
12/28/2006	WO2006137350A1 Novel furopyridine derivative, pharmaceutical composition comprising the derivative, and use of the derivative or composition
12/28/2006	WO2006137341A1 Agent for visualizing vitreous body
12/28/2006	WO2006137314A1 Radial brush
12/28/2006	WO2006137258A1 Pharmaceutical composition comprising azarhodacyanine compound as active ingredient
12/28/2006	WO2006137222A1 Method for control of drug elution rate and composition for coating of drug-eluting stent
12/28/2006	WO2006137172A1 Pest control agent of fungi or parasites for fish
12/28/2006	WO2006137092A1 Fluorescent sulfonamide derivatives having carbonic anhydrase inhibiting activity and their use as theapeutic and diagnostic agents
12/28/2006	WO2006137019A1 Novel thiophene derivatives
12/28/2006	WO2006136945A1 METABOLITES OF 1&lowbar; [&lowbar;6- (1-ETHYL-l-HYDROXY-PROPYL) -PYRIDIN-3-YL] -3- [2- (4-METHYL-PIPERAZIN-I-YL) -BE NZYL] -PYRR0LIDIN-2-0NE AS SERATONIN RECEPTOR ANTAGONISTS
12/28/2006	WO2006136927A1 Extended release formulations comprising venlafaxine
12/28/2006	WO2006136924A1 Histamine-3 receptor antagonists
12/28/2006	WO2006136917A1 Triazolylpiperidine derivatives and use thereof in therapy
12/28/2006	WO2006136916A2 Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
12/28/2006	WO2006136857A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors
12/28/2006	WO2006136841A1 Multiple sclerosis therapy and diagnosis
12/28/2006	WO2006136830A1 Aryl-alkylamines and heteroaryl-alkylamines as protein kinase inhibitors
12/28/2006	WO2006136823A1 Heterocyclic containing amines as kinase b inhibitors
12/28/2006	WO2006136822A1 Inhibitor compounds
12/28/2006	WO2006136821A1 Pharmaceutical compounds
12/28/2006	WO2006136806A1 Thiazolopyrimidines for use in therapy

1 ... 3943 3944 3945 3946 3947 3948 3949 3950 3951 3952 3953 3954 3955 3956 3957 3958 3959 3960 3961 3962 3963 ... 7860